In our country to develop efficient liver cancer detection kits

On October 20, 2016 08:22

Source: People's Daily - the People's Daily

People in Beijing on October 19 (reporter yong-xin zhao, zhao graceful) 19, reporters learned from tsinghua university, the school yongzhang luo team in the world for the first time prove that the tumor markers of heat shock protein 90 (Hsp90 alpha) spans, has been run by the state food and drug administration approved for clinical detection of liver cancer. The expert points out, Hsp90 alpha is the world's first defined by Chinese scientists and approved for use in clinical efficient broad-spectrum tumor markers, its early detection rate of liver cancer is more than twice the current method.

Yongzhang luo team with extraordinary method to capture human plasma Hsp90 protein alpha stable state, and on this basis, developed the high sensitivity, good specificity of antibody, thus developed can be used for clinical Hsp90 alpha quantitative detection kit. Since then has launched the world's first to Hsp90 alpha as a marker of liver cancer clinical trials. Three main types of liver cancer patients, according to the results of the plasma concentration of Hsp90 alpha were significantly higher than that of healthy people and patients with non cancer related diseases. Even more exciting, in liver cancer patients with AFP test results were negative, Hsp90 alpha detection rate is as high as 94%. These results show that: Hsp90 alpha is currently the world's most superior performance of liver cancer markers.

The People's Daily (October 20, 2016, 11)